ArticleGland surgery2024
Causal effects of thyroid volume change on thyroid disease: a Mendelian randomization study.
Article in Gland surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Observational studies have suggested an association between thyroid volume changes and thyroid disease, but the causal relationship and direction of these effects remain unclear. This study employs a two-sample Mendelian randomization (MR) approach to assess the effect of thyroid volume on clinically common benign and malignant thyroid diseases. Methods: Summary data from genome-wide association studies (GWAS) were utilized for secondary data analysis to investigate the link between thyroid volume and disease. Gene loci strongly associated with thyroid volume were selected as the instrumental variables. Five complementary two-sample MR methods were used to evaluate the causal effect of thyroid volume on thyroid diseases and thyroid stimulating hormone (TSH). Results: Thyroid volume was found to be significantly associated with autoimmune thyroid disease [odds ratio (OR) =1.045; 95% confidence interval (CI): 1.022-1.069; P<0.001], Hashimoto's thyroiditis (OR =1.800; 95% CI: 1.167-2.778; P=0.008), Graves' disease (OR =0.136; 95% CI: 0.065-0.282; P<0.001), hyperthyroidism (OR =1.011; 95% CI: 1.008-1.014; P<0.001), multinodular goiters (OR =121.541; 95% CI: 23.323-633.378; P<0.001), non-toxic single thyroid nodules (OR =7.536; 95% CI: 2.280-24.911; P<0.001), benign thyroid neoplasms (OR =4.300; 95% CI: 1.170-15.802; P=0.03), and TSH levels (OR =0.401; 95% CI: 0.247-0.652; P<0.001). Thyroid volume was negatively associated with thyroid carcinomas (OR =0.401; 95% CI: 0.208-0.772; P=0.006; β =-0.915). Conclusions: Our study found that there is a causal relationship between thyroid volume and some thyroid diseases, and that increased thyroid volume levels exert protective effects on thyroid carcinoma. Monitoring thyroid volume may be of value in the prevention of clinical thyroid diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.